Dixon et al used a modification of the criteria proposed by Lee for the histologic scoring of liver biopsies from patients with nonalcoholic steatohepatitis (NASH). This can be used during the initial evaluation of the patient; it can also be used later to monitor disease progression and the impact of therapeutic interventions.